Allogeneic Transplantation to Treat Therapy-Related Myelodysplastic Syndrome and Acute Myelogenous Leukemia in Adults

L. Metheny*, N.S. Callander, A.C. Hall, M.J. Zhang, K. Bo-Subait, H.L. Wang, V. Agrawal, A.S. Al-Homsi, A. Assal, U. Bacher, A. Beitinjaneh, N. Bejanyan, V.R. Bhatt, C. Bredeson, M. Byrne, M. Cairo, J. Cerny, Z. DeFilipp, M.A.D. Perez, E.O. FreytesS. Ganguly, M.R. Grunwald, S. Hashmi, G.C. Hildebrandt, Y. Inamoto, C.G. Kanakry, M.A. Kharfan-Dabaja, H.M. Lazarus, J.W. Lee, S. Nathan, T. Nishihori, R.F. Olsson, O. Ringden, D. Rizzieri, B.N. Savani, M.L. Savoie, S. Seo, M. van der Poel, L.F. Verdonck, J.L. Wagner, J.A. Yared, C.S. Hourigan, P. Kebriaei, M. Litzow, B.M. Sandmaier, W. Saber, D. Weisdorf, M. de Lima

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

2 Citations (Web of Science)
Original languageEnglish
Number of pages12
JournalTransplantation and Cellular Therapy
Volume27
Issue number11
DOIs
Publication statusPublished - 1 Nov 2021

Keywords

  • Allogeneic transplantation
  • Acute myelogenous leukemia
  • Myelodysplasia
  • ACUTE MYELOID-LEUKEMIA
  • HEMATOPOIETIC-CELL TRANSPLANTATION
  • BREAST-CANCER THERAPY
  • CHEMOTHERAPY
  • RISK
  • AML
  • MALIGNANCIES
  • MAINTENANCE
  • SECONDARY
  • LYMPHOMA

Cite this